Top Markets
Coin of the day
NeuroSense Therapeutics Ltd. NeuroSense Therapeutics Ltd.

NeuroSense Therapeutics Ltd.

NRSN
Rang in aandelen #31255
NeuroSense Therapeutics Ltd. operates as a biotechnology firm in the clinical... NeuroSense Therapeutics Ltd. operates as a biotechnology firm in the clinical development phase, committed to discovering and developing effective therapies for individuals suffering from severe neurodegenerative conditions. The company's leading drug candidate, PrimeC, is an innovative oral formulation that has successfully concluded Phase IIa clinical investigations for the management of amyotrophic lateral sclerosis (ALS). Additionally, its early-stage research pipeline features StabiliC, a potential treatment for Parkinson's disease, and CogniC, which is under development for Alzheimer's disease. Established in 2017, NeuroSense Therapeutics Ltd. is headquartered in Herzliya, Israel.
Aandeelprijs
$0.39
Marktkapitalisatie
$13.79M
Verandering (1 dag)
-13.53%
Verandering (1 jaar)
-68.80%
Land
IL
Handel NeuroSense Therapeutics Ltd. (NRSN)

Categorie

Koersgeschiedenis voor NeuroSense Therapeutics Ltd. (NRSN)
Hoogste slotkoers: $0.47 op 2026-08-01

Laagste slotkoers: $3.04 op 2021-12-01
Koersgeschiedenis van NeuroSense Therapeutics Ltd. van 2021 tot 2026
Jaarlijkse koersprestatie
Jaar Prestaties
2026 (TTM) -1.04%
2025 -17.69%
2024 31.68%
2023 -42.23%
2022 -51.82%
2021 0.00%
Aandelenkoers van vergelijkbare bedrijven of concurrenten
Bedrijf Aandelenkoers Verandering 1jr% Land
$527.89 35.40%
US
$996.61 50.70%
NL
$111.31 -36.83%
AU
$735.86 6.87%
CH
$257.75 13.01%
BE